汉商集团：迪康药业为两家子公司提供4000万元新增担保

观点网10-17

观点网讯：10月17日，汉商集团发布公告，披露了成都迪康药业股份有限公司为重庆迪康长江制药有限公司和成都迪康中科生物医学材料有限公司提供担保的进展情况。根据公告，新增担保金额为4000万元，使得已担保总额达到2.48亿元，占公司2023年期末净资产的14.82%。迪康长江作为被担保方之一，其财务状况显示，总资产为3.88亿元，净资产为9195.20万元，营业收入为3.9亿元，净利润为4133.18...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2476118236?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-17 17:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2476118236","market":"sh","top_or_hot":-1,"title":"汉商集团：迪康药业为两家子公司提供4000万元新增担保","media":"观点网","content":"<div>\n<p>观点网讯：10月17日，汉商集团发布公告，披露了成都迪康药业股份有限公司为重庆迪康长江制药有限公司和成都迪康中科生物医学材料有限公司提供担保的进展情况。根据公告，新增担保金额为4000万元，使得已担保总额达到2.48亿元，占公司2023年期末净资产的14.82%。迪康长江作为被担保方之一，其财务状况显示，总资产为3.88亿元，净资产为9195.20万元，营业收入为3.9亿元，净利润为4133.18...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101717043495af28d9&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>汉商集团：迪康药业为两家子公司提供4000万元新增担保</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n汉商集团：迪康药业为两家子公司提供4000万元新增担保\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-17 17:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101717043495af28d9&s=b><strong>观点网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>观点网讯：10月17日，汉商集团发布公告，披露了成都迪康药业股份有限公司为重庆迪康长江制药有限公司和成都迪康中科生物医学材料有限公司提供担保的进展情况。根据公告，新增担保金额为4000万元，使得已担保总额达到2.48亿元，占公司2023年期末净资产的14.82%。迪康长江作为被担保方之一，其财务状况显示，总资产为3.88亿元，净资产为9195.20万元，营业收入为3.9亿元，净利润为4133.18...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101717043495af28d9&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101717043495af28d9&s=b","article_id":"2476118236","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101717043495af28d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2476118236","pubTimestamp":1729155660,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"观点网讯：10月17日，汉商集团发布公告，披露了成都迪康药业股份有限公司为重庆迪康长江制药有限公司和成都迪康中科生物医学材料有限公司提供担保的进展情况。而迪康中科的总资产为1.25亿元，净资产为8580.70万元，营业收入为7627.03万元，净利润为2700.04万元，资产负债率为31%。公告还指出，汉商集团的逾期担保数量为无，对外担保逾期累计数量同样为无，且不存在反担保情况。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600774":"汉商集团","BK0239":"医药制造","BK0209":"零售"},"translate_title":"Hanshang Group: Dikang Pharmaceutical provides 40 million yuan in new guarantee for two subsidiaries","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600774":1},"content_text":"观点网讯：10月17日，汉商集团发布公告，披露了成都迪康药业股份有限公司为重庆迪康长江制药有限公司和成都迪康中科生物医学材料有限公司提供担保的进展情况。根据公告，新增担保金额为4000万元，使得已担保总额达到2.48亿元，占公司2023年期末净资产的14.82%。迪康长江作为被担保方之一，其财务状况显示，总资产为3.88亿元，净资产为9195.20万元，营业收入为3.9亿元，净利润为4133.18万元，资产负债率为76%。而迪康中科的总资产为1.25亿元，净资产为8580.70万元，营业收入为7627.03万元，净利润为2700.04万元，资产负债率为31%。公告还指出，汉商集团的逾期担保数量为无，对外担保逾期累计数量同样为无，且不存在反担保情况。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2476118236"}